The CD123 antibody–drug conjugate pivekimab sunirine exerts profound activity in preclinical models of pediatric acute lymphoblastic leukemia by Ben Watts, Christopher M. Smith, Kathryn Evans, Andrew J. Gifford, Sara M. A. Mohamed, Stephen W. Erickson, Eric J. Earley, Steven Neuhauser, Timothy M. Stearns, Vivek M. Philip, Jeffrey H. Chuang, Patrick A. Zweidler‐McKay, Sribalaji Lakshmikanthan, Emily L. Jocoy, Carol J. Bult, Beverly A. Teicher, Malcolm A. Smith, Richard B. Lock

Get full text

A comparative study of target fabrication strategies for microgram muonic atom spectroscopy by L. Antwis, S. Bara, C. Bruhn, T. E. Cocolios, M. Deseyn, A. Doinaki, Ch. E. Düllmann, J. Fletcher, M. Heines, R. Heller, P. Indelicato, U. Kentsch, T. Kieck, K. Kirch, A. Knecht, E. A. Maugeri, M. Niikura, A. Ouf, L. M. C. Pereira, W. W. M. M. Phyo, R. Pohl, D. Renisch, N. Ritjoho, A. Vantomme, S. M. Vogiatzi, K. von Schoeler, F. Wauters, A. Zendour, S. Zweidler

Get full text

A phase 1B/2 study of the CD123-targeting antibody-drug conjugate pivekimab sunirine (IMGN632) in combination with venetoclax (VEN) and azacitidine (AZA) for patients with CD123-po... by Daver, NG, Montesinos, P, Aribi, A, Martinelli, G, Altman, J, Roboz, G, Wang, ES, Burke, PW, Jeyakumar, D, Walter, RB, DeAngelo, DJ, Erba, HP, Advani, A, Gastaud, L, Thomas, X, Todisco, E, Pemmaraju, N, Mendez, L, de la Fuente, A, Gaidano, G, Curti, A, Boissel, N, Recher, C, Schliemann, C, Vyas, P, Sloss, CM, Wang, J, Malcolm, KA, Zweidler‐McKay, PA, Sweet, KL

MLL-rearranged acute lymphoblastic leukemias activate BCL-2 through H3K79 methylation and are sensitive to the BCL-2-specific antagonist ABT-199 by Benito, J, Godfrey, L, Kojima, K, Hogdal, L, Wunderlich, M, Geng, H, Marzo, I, Harutyunyan, K, Golfman, L, North, P, Kerry, J, Ballabio, E, Chonghaile, T, Gonzalo, O, Qiu, Y, Jeremias, I, Debose, L, O'Brien, E, Ma, H, Zhou, P, Jacamo, R, Park, E, Coombes, K, Zhang, N, Thomas, D, O'Brien, S, Kantarjian, H, Leverson, J, Kornblau, S, Andreeff, M, Müschen, M, Zweidler-McKay, P, Mulloy, J, Letai, A, Milne, T, Konopleva, M

AML-262 Pivekimab Sunirine (PVEK, IMGN632) triplet with azacitidine and venetoclax shows broad activity in adverse genetic subsets of relapsed/refractory acute myeloid leukemia and... by Daver, N, Montesinos, P, Aribi, A, Martinelli, G, Altman, JK, Wang, ES, Roboz, GJ, Burke, PW, Gaidano, G, Walter, RB, Thomas, X, Jeyakumar, D, DeAngelo, DJ, Erba, HP, Todisco, E, Begna, K, Advani, A, Gastaud, L, de la Fuente, A, Curti, A, Mendez, LM, Vyas, P, Boissel, N, Vey, N, Recher, C, Longval, T, Platzbecker, U, Kapp-Schwörer, S, Schliemann, C, Konopleva, M, Torres, L, Sallman, DA, Marcucci, G, Marconi, G, Kantarjian, H, Sloss, CM, Malcolm, KE, Zweidler-McKay, PA, Sweet, K